Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

PHASE2TerminatedINTERVENTIONAL
Timeline

Start Date

May 31, 2007

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

autologous immunoglobulin idiotype-KLH conjugate vaccine

Trial Locations (9)

10021

Weill Medical College of Cornell University, NY Presbyterian Hospital, New York

28204

Carolinas Medical Center, Charlotte

46202

Indiana University Medical Center, Indianapolis

73174

University of Oklahoma Health Science Center, Oklahoma City

80218

Rocky Mountain Cancer Centers, Denver

90089

Keck School of Medicine of University Southern California, Los Angeles

97213

Providence Portland Cancer Center, Portland

02115

Dana-Farber Cancer Institute, Boston

68198-7680

University of Nebraska Medical Center, Omaha

Sponsors
All Listed Sponsors
lead

Genitope Corporation

INDUSTRY